Summary
Synopsys Inc. reported solid financial results for the quarter and six months ended April 30, 2016, demonstrating continued revenue growth and profitability. Total revenue increased by 9% year-over-year for the quarter and 7% for the six-month period, primarily driven by an increase in time-based license revenue, which continues to represent the majority of the company's revenue. The company's strong operational performance is supported by its robust time-based revenue model, which provides a predictable revenue stream. Synopsys also maintained a healthy cash position, with cash, cash equivalents, and short-term investments totaling $959.9 million. The company continued to execute on its strategic objectives, including investments in research and development and acquisitions, while also actively managing its capital through stock repurchases.
Financial Highlights
53 data points| Revenue | $605.00M |
| Cost of Revenue | $131.63M |
| Gross Profit | $473.38M |
| R&D Expenses | $216.17M |
| Operating Expenses | $386.57M |
| Operating Income | $86.81M |
| Interest Expense | $848K |
| Net Income | $69.38M |
| EPS (Basic) | $0.46 |
| EPS (Diluted) | $0.45 |
| Shares Outstanding (Basic) | 152.25M |
| Shares Outstanding (Diluted) | 154.54M |
Key Highlights
- 1Total revenue increased by 9% to $605.0 million for the three months ended April 30, 2016, compared to $557.2 million in the prior year period.
- 2Time-based license revenue, the company's primary revenue stream, grew 8% to $484.2 million for the quarter.
- 3Gross margin remained strong at 78% for the quarter, indicating effective cost management.
- 4Research and development expenses increased by 15% to $216.2 million, reflecting continued investment in innovation.
- 5Net income increased by 25% to $69.4 million for the quarter, showcasing improved profitability.
- 6The company maintained a healthy liquidity position with $959.9 million in cash, cash equivalents, and short-term investments as of April 30, 2016.
- 7Synopsys repurchased approximately $20.0 million of its common stock during the quarter.